Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Ohio Attorney General Dave Yost has approved the official title and summary language for a proposed referendum that seeks to roll back the state’s recent changes to its recreational marijuana laws. The decision clears a major procedural hurdle for advocates who want voters to weigh in on Senate Bill 56, a measure adopted by lawmakers late last year.
Ohio Attorney General Dave Yost has approved the official title and summary language for a proposed referendum that seeks to roll back the state’s recent changes to its recreational marijuana laws. The decision clears a major procedural hurdle for advocates who want voters to weigh in on Senate Bill 56, a measure adopted by lawmakers late last year.
Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery
Virginia legislators have advanced legislation that would legalize and oversee adult-use marijuana sales in the state. The proposal is one of several drug policy measures being debated during the 2026 legislative session.
Virginia legislators have advanced legislation that would legalize and oversee adult-use marijuana sales in the state. The proposal is one of several drug policy measures being debated during the 2026 legislative session.
Tilray shares edged higher in premarket trading after the company rebranded its Italy unit as Tilray Medical Italia and highlighted expansion plans in the regulated medical cannabis market.
NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the entity previously known as FL Group.
As the legal marijuana sector enters another year of adjustment, new data points show an industry still working to find its footing. While some long-standing challenges remain unresolved, recent developments suggest parts of the market may finally be moving toward a more sustainable balance.
As the legal marijuana sector enters another year of adjustment, new data points show an industry still working to find its footing. While some long-standing challenges remain unresolved, recent developments suggest parts of the market may finally be moving toward a more sustainable balance.
As of January 9, 2026, the cannabis sector finds itself at a historic crossroads, caught between the euphoria of federal progress and the harsh reality of market mechanics. Following a landmark Executive Order in late 2025 aimed at accelerating the rescheduling of marijuana, the industry has entered the new year
